8:45-8:55 am:

Opening and Welcome Remarks

Sujuan Ba, Ph.D., CEO of NFCR, Co-Founder of AIM-HI, & Founder of AFCR

8:45-10:30 am:

Moderator: Web Cavenee, Ph.D., Chair of NFCR Scientific Advisory Board; Distinguished Professor of Medicine, University of California, San Diego and Director of Strategic Alliances, Ludwig Institute for Cancer Research

Panel Members:

• Ken C. Anderson, M.D., Dana-Farber Cancer Institute, Professor of Medicine, Harvard; Physician Oncology, Brigham and Women’s Hospital
• Teresa Davoli, Ph.D., Assistant Professor, Cancer Genetics and Genomics, New York University
• Aaron N. Hata, M.D., Ph.D., Assistant Professor of Medicine, Harvard 
• Isidore Rigoutsos, Ph.D., Professor in Computational Medicine, Thomas Jefferson University
• Suzanne Topalian, M.D., Professor of Oncology and Surgery, Johns Hopkins University
• Katherine Uyhazi, M.D., Ph.D., Assistant Professor of Ophthalmology, University of Pennsylvania 

10:45am-12:20 pm:

Moderator: Jennifer Grandis, M.D., American Cancer Society Professor of Otolaryngology, University of California, San Francisco

Panel Members: 

• Lisa Coussens, Ph.D., Professor and Chair, Department of Cell, Developmental & Cancer Biology, Oregon Health and Sciences University
• Daniel A. Haber, M.D., Ph.D., Director, Massachusetts General Hospital Cancer Center
• Courtney Houchen, M.D., Professor, Chief of Digestive Diseases and Nutrition, Oklahoma University School of Medicine
• Daniel E. Johnson, Ph.D., Professor and Vice Chair of Research, Otolaryngology and Head and Neck Surgery, University of California, San Francisco
• Kornelia Polyak, M.D., Ph.D., Professor of Medicine, Dana-Farber Cancer Institute, Harvard 
• Xiang-Lei Yang, Ph.D., Professor of Molecular Biology and Medicine, Scripps Research

12:20-12:25 pm:

Closing Remarks: 

Alfred Slanetz, Ph.D. Chairman of Board of Directors, NFCR; CEO of Geneius Biotechnology

12:30-2:00 pm:

Emcee: Rose Wang, MBA, Executive Advisor of AIM-HI Accelerator Fund

Introduction of the AIM-HI Leadership & Entrepreneurship program: 

Sujuan Ba, Ph.D., CEO of NFCR, Co-Founder of AIM-HI, & Founder of AFCR

Award Presentation of the AIM-HI Beacon Award for Women Leaders in Oncology

• Overview of the Beacon Award Selection Process: Web Cavenee, Ph.D., Co-Chair of the Selection Committee of the Beacon Award
• Introduction of the Awardee by the Nominator, Raju Kucherlapati, Ph.D., Paul C. Cabot Professor of Genetics and Professor of Medicine, Harvard Medical School
• Presenting the Beacon Award Medallion to the Recipient by the Award Selection Committee Members
• 2022 Beacon Award Winner Award Speech: Anna Barker, Ph.D., Chief Strategy Officer of Ellison Institute for Transformative Medicine 

Award Presentation of the Top Finalists for the 2022 Women’s Venture Competition & 2022 BRACE Award Venture Competition: Pamela Garzone, Ph.D., Co-Chair of the Competition Selection & Judging Committees; Chief Development Officer of Anixa Biosciences 

Women’s Venture Competition: Dimitra Georganopoulou, Ph.D., Co-Chair of the Competition Investment Committee; General Partner of Qral Ventures

• Johanna Webb, President of RiverWalk Therapeutics
• Revital Mandil-Levin, Ph.D., CEO & Co-Founder of Nanocarry Therapeutics
• Rosa Hwang, M.D., Co-Founder of Stellanova Therapeutics

BRACE Award Venture Competition: Beverly Lu, Ph.D., Co-Chair of the Competition Investment Committee; Investment Manager, Health of Emerson Collective

• Li Chai, M.D., Co-Founder of Believer Pharmaceuticals
• Rajiv Datar, Ph.D., Co-Founder & CEO of Propelle Therapeutics

Closing Remarks: Rose Wang

2:15-4:00 pm:

Welcome and Opening Remarks: 

Sujuan Ba, Ph.D., CEO of NFCR, Co-Founder of AIM-HI, & Founder of AFCR

Presentation: 

• Lora Green, Ph.D., J.D., Partner, Patents & Innovations, Wilson Sonsini Goodrich & Rosati: 
• Critical Intellectual Property Protection Strategies & Common Pitfalls for Early-stage Companies

Panel Discussion: Opportunities & Challenges Facing Leadership of Early-stage Oncology Companies

Moderator: Raju Kucherlapati, Ph.D., Paul C. Cabot Professor of Genetics and Professor of Medicine, Harvard Medical School

Panel Members:

• Pritesh Gandhi, PharmD, CEO of TellBio
• Vlad Hogenhuis, M.D., MBA, CEO of Chimera Bioengineering
• John Luk, DMedSc, EMBA, CEO of Arbele Bio
• Ken Malone, Ph.D., CEO of Rasio Therapeutics
• María Varela, CEO of Ardan Pharma

Closing Remarks: 

Charlie Weatherspoon, Chair of the Board of the Director, AIM-HI Accelerator Fund

6:00-7:00 pm:

Cocktail Reception

7:00-8:30 pm:

Dinner & Award Ceremony

Moment of Silence

Opening and Welcome Remarks: Sujuan Ba, Ph.D., CEO of NFCR, Co-Founder of AIM-HI, & Founder of AFCR; Co-Chair of the 2022 Selection Committee for the Szent-Györgyi Prize

Introduction of the 2022 Szent-Györgyi Prize Winner:

Doug Lowy, M.D., 2018 Szent-Györgyi Prize Winner; Principal Deputy Director of the U.S. National Cancer Institute 

Award Trophy Presentation: 

Dr. Sujuan Ba, Co-Chair of the 2022 Selection Committee for the Szent-Györgyi Prize

2022 Szent-Györgyi Prize Winner Award Speech: 

Rakesh K. Jain, Ph.D., Andrew Werk Cook Professor of Radiation Oncology, Harvard Medical School; Director, Edwin L. Steele Laboratories for Tumor Biology, Massachusetts General Hospital

Introduction of Lance Kawaguchi, Board Member of NFCR & Chair of AFCR; CEO of Cure Brain Cancer Foundation: Sujuan Ba, Ph.D.

Introduction of Cancer Research Advocates: Lance Kawaguchi

Chelsea Hu, BASIS Independent, McLean

Greyson and Katie Banovich: Phoenix, AZ

Acknowledgments & Closing Remarks: Lance Kawaguchi